rilpivirine and its Impurities
A second-generation non-nucleoside reverse transcriptase inhibitor drug, Rilpivrine is used for the treatment of HIV/AIDS. A diarylpyrimidine derivative.Reference standards of Rilpivirine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.


(Z)-2-(4-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)amino)-3,5-dimethylbenzylidene)-3-(4-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3,5-dimethylphenyl)pentanedinitrile
(Z)-2-(4-((2-((4-Cyanophenyl)amino)pyrimidin-4-yl)amino)-3,5-dimethylbenzylidene)-3-(4-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3,5-dimethylphenyl)pentanedinitrile
Catalogue No.:PA 18 0221005
CAS :
NA
Molecular Formula : C44H36N12
Molecular Weight : 732.86


(E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)(3,4-dihydroxy-6-(hydroxymethyl)-5-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)amino)pyrimidin-2-yl)amino)benzonitrile compound with (E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)(3,5,6-trihydroxy-2-oxo-4-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexyl)amino)pyrimidin-2-yl)amino)benzonitrile (1:1)
(E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)(3,4-dihydroxy-6-(hydroxymethyl)-5-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)amino)pyrimidin-2-yl)amino)benzonitrile compound with (E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)(3,5,6-trihydroxy-2-oxo-4-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexyl)amino)pyrimidin-2-yl)amino)benzonitrile (1:1)
Catalogue No.:PA 18 0221006
CAS :
NA
Molecular Formula : C34H38N6O10
Molecular Weight : 690.71


(E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)(3,4-dihydroxy-6-(hydroxymethyl)-5-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)amino)benzonitrile compound with (E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)(3,5,6-trihydroxy-2-oxo-4-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexyl)amino)benzonitrile (1:1)
(E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)(3,4-dihydroxy-6-(hydroxymethyl)-5-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)amino)benzonitrile compound with (E)-4-((4-((4-(2-Cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)(3,5,6-trihydroxy-2-oxo-4-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexyl)amino)benzonitrile (1:1)
Catalogue No.:PA 18 0221007
CAS :
NA
Molecular Formula : C34H38N6O10
Molecular Weight : 690.71


(E)-N-(2-((4-Cyanophenyl)amino)pyrimidin-4-yl)-N-(4-(2-cyanovinyl)-2,6-dimethylphenyl)nitrous amide
(E)-N-(2-((4-Cyanophenyl)amino)pyrimidin-4-yl)-N-(4-(2-cyanovinyl)-2,6-dimethylphenyl)nitrous amide
Catalogue No.:PA 18 0221009
CAS :
NA
Molecular Formula : C22H17N7O
Molecular Weight : 395.43


(E)-N-(4-Cyanophenyl)-N-(4-((4-(2-cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)nitrous Amide
(E)-N-(4-Cyanophenyl)-N-(4-((4-(2-cyanovinyl)-2,6-dimethylphenyl)amino)pyrimidin-2-yl)nitrous Amide
Catalogue No.:PA 18 0221016
CAS :
NA
Molecular Formula : C22H17N7O
Molecular Weight : 395.43